The exact text we saved

This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.

TRUVACE RECORD VERSION
record: TRV-2026-1156
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-09-21T06:53:26.163147Z
status: published
lens: g_space
sector: health
headline: Smartphone AI-Enabled Lateral Flow Immunoassay Platform Using Advanced Quantum Dots for Intelligent Quantitative Diagnostics
dek: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV). The platform combines three synergistic princi…
gain_title: Smartphone AI-Enabled Lateral Flow Immunoassay Platform Using Advanced Quantum Dots for Intelligent Quantitative Diagnostics: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity.
problem_title: (none)
trace_subject: (none)
gain_reading: Smartphone AI-Enabled Lateral Flow Immunoassay Platform Using Advanced Quantum Dots for Intelligent Quantitative Diagnostics: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity.
gain_evidence: (none)
problem_reading: (none)
problem_evidence: (none)
quick_read: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV).

By coupling dual-modal amplification and magnetic enrichment with AI-driven analysis on widely available hardware, the AQD-LFIA platform offers a scalable route toward next-generation point-of-care and at-home diagnostics.
limitation: 
tag: Evidence-backed gain
key_points: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. | Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV). | The platform combines three synergistic principles: advanced magnetic quantum dot nanoparticles (AQDs) that integrate a magnetic core and a quantum dot shell in a single label to provide both colorimetric and fluorescence signals while enabling magnetic preconcentration of the target antigen; multi-illumination imaging that turns an ordinary smartphone camera into a quantitative reader; and a machine-learning model that extracts illumination-robust features to convert signal into concentration, removing user subjectivity and lighting sensitivity.
rundown: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV).

The platform combines three synergistic principles: advanced magnetic quantum dot nanoparticles (AQDs) that integrate a magnetic core and a quantum dot shell in a single label to provide both colorimetric and fluorescence signals while enabling magnetic preconcentration of the target antigen; multi-illumination imaging that turns an ordinary smartphone camera into a quantitative reader; and a machine-learning model that extracts illumination-robust features to convert signal into concentration, removing user subjectivity and lighting sensitivity. This design markedly improves sensitivity over conventional gold-nanosphere LFIA in both modes, enables reliable quantification directly in serum without any pretreatment, and outperforms naked-eye interpretation in blind testing.
sources:
- peer_reviewed | ACS Applied Materials & Interfaces | https://doi.org/10.1021/acsami.6c10769 | 2026-09-21
prev: 0000000000000000000000000000000000000000000000000000000000000000

SHA-256 hash

d3c3b525ad944e58bc5b58e611d70fd55d2abbddf825008215579083cb839f7a

Previous version’s hash

0000000000000000000000000000000000000000000000000000000000000000